Evidence map›Paper›PMID 36604357›Full record

ArticleClinical rheumatology2023

Bibliometric and altmetric analysis of research relating to antiphospholipid syndrome based on VOS viewer (2011-2021).

Youxian He, Mengxiang Li, Hao Yu, Feng Yin, Xue Zhang, Qiuyu Yang, Xintong Xie, Guangliang Wei, Huidong Chen, Chengsong He and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Youxian He *Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Mengxiang Li *Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Hao YuDepartment of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Feng YinDepartment of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Xue ZhangDepartment of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Qiuyu YangDepartment of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Xintong XieDepartment of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Guangliang WeiDepartment of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Huidong ChenDepartment of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Chengsong HeDepartment of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Yue HeDepartment of Ophthalmology, The Affiliated Hospital of Southwest Medical University, No. 25, Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China.
Jie ChenDepartment of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, No. 25,Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan Province, People's Republic of China. cjlion@qq.com.ORCID http://orcid.org/0000-0001-5696-9070
Affiliated Hospital of Southwest Medical University · CNSouthwest Medical University · CN

Funding

Affiliated Hospital of Southwest Medical University No. 18048Health Department of Sichuan Province 150078Sichuan Education Department 18ZB0640Southwest Medical University 07092Technology Department in Sichuan Province 20YYJC20150Youth Innovation in Medical Research in Sichuan Province Q15027
6 · The paper itself

Abstract

backgroundAntiphospholipid syndrome is an autoimmune disorder characterized by recurrent vascular thrombosis and pregnancy losses in the presence of persistently positive antiphospholipid antibodies. Bibliometric analysis and altmetric analysis are methods of analyzing academic productivity and influence. Currently, the assessment of antiphospholipid syndrome through the above analyses is lacking. This study investigated the quantity and quality of studies in the field of antiphospholipid syndrome and revealed the characteristics of worldwide productivity on this disease by the bibliometric analysis and altmetric analysis.

methodsThe terms "APS," "antiphospholipid syndrome," "antiphospholipid-antibody syndrome," and "Hughes syndrome" were searched on the Web of Science Core Collection from January 1, 2011, to December 31, 2021. Original articles and reviews were selected. We set the filters as "English." RESULTS AND

conclusionA total of 1818 articles were retrieved from 68 countries, of which 20 met the criteria of major active countries. High-income countries contributed 1341 articles (73.48%). The number of articles annually increased significantly in the 10-year period (P < 0.001). The USA (253, 13.91%) was the most productive country. Adjusted by population, Serbia was top of the list. According to the gross domestic product analysis, Serbia ranked first. The most used keywords such as thrombosis and antiphospholipid antibodies were presented by keywords analyses. A content analysis found antithrombotic and anticoagulant therapy as research hotspots. A significant correlation was detected between average citations and altmetric attention scores (P = 0.002) and Mendeley readers count (P < 0.001). From 2011 to 2021, the number of global articles increased rapidly. Most papers came from high-income countries. The relationship between the bibliometric and altmetric analyses were basically consistent; therefore the two can prove/complement each other. Key points • We revealed the global productivity characteristics of the papers related to antiphospholipid syndrome by using the methods of bibliometric analysis and altmetric analysis. • We found the most selected articles that describe the treatment of antiphospholipid syndrome, especially antithrombotic and anticoagulant treatments, which may be the current research hotspot.

Indexed as

Antiphospholipid SyndromeBibliometricsAntibodies, AntiphospholipidAnticoagulantsFibrinolytic AgentsHumansThrombosisAntibodies, AntiphospholipidAnticoagulantsFibrinolytic AgentsAltmetric attention scoresAntiphospholipid-antibody syndromeAntiphospholipid syndromeBibliometric analysisWeb of Science

Identifiers

PMID36604357
OpenAlexW4313540562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.